244 related articles for article (PubMed ID: 16178446)
21. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
[TBL] [Abstract][Full Text] [Related]
22. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
23. Expression of matrix metalloproteinase-1 mRNA in peripheral blood mononuclear cells of systemic lupus erythematosus patients and its relationship with atherosclerosis.
Zhang HY; Bao SM; Shou WL; Luan HX; Zhang Y; Feng X; Tong DW; Zhang SL; Hu CJ; Zeng XF; Li YZ
Chin Med J (Engl); 2009 Nov; 122(21):2593-7. PubMed ID: 19951575
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus.
Narumi S; Takeuchi T; Kobayashi Y; Konishi K
Cytokine; 2000 Oct; 12(10):1561-5. PubMed ID: 11023674
[TBL] [Abstract][Full Text] [Related]
25. Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
Nephrology (Carlton); 2006 Jun; 11(3):219-25. PubMed ID: 16756635
[TBL] [Abstract][Full Text] [Related]
26. Elevated interleukin-13 in patients with active lupus nephritis.
Chen X; Zhang Z; Jiang L; Ye F; Wang J; Wu P
Chin Med J (Engl); 2001 Oct; 114(10):1022-5. PubMed ID: 11677758
[TBL] [Abstract][Full Text] [Related]
27. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
28. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus.
Komatsuda A; Wakui H; Iwamoto K; Togashi M; Maki N; Masai R; Hatakeyama T; Sawada K
Clin Immunol; 2007 Oct; 125(1):26-9. PubMed ID: 17683987
[TBL] [Abstract][Full Text] [Related]
30. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
31. Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys.
Boonla C; Hunapathed C; Bovornpadungkitti S; Poonpirome K; Tungsanga K; Sampatanukul P; Tosukhowong P
BJU Int; 2008 May; 101(9):1170-7. PubMed ID: 18241247
[TBL] [Abstract][Full Text] [Related]
32. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).
Schiffer L; Kümpers P; Davalos-Misslitz AM; Haubitz M; Haller H; Anders HJ; Witte T; Schiffer M
Nephrol Dial Transplant; 2009 Dec; 24(12):3708-12. PubMed ID: 19602475
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
34. [Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus].
Tang JP; Gu YY; Shen N; Ye S; Qian J; Hua J; Chen XG; Chen SL; Bao CD; Wang Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1157-60. PubMed ID: 15387975
[TBL] [Abstract][Full Text] [Related]
35. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus.
Iikuni N; Okamoto H; Yoshio T; Sato E; Kamitsuji S; Iwamoto T; Momohara S; Taniguchi A; Yamanaka H; Minota S; Kamatani N
Ann Rheum Dis; 2006 Feb; 65(2):253-6. PubMed ID: 16410530
[TBL] [Abstract][Full Text] [Related]
36. Urinary TWEAK and the activity of lupus nephritis.
Schwartz N; Su L; Burkly LC; Mackay M; Aranow C; Kollaros M; Michaelson JS; Rovin B; Putterman C
J Autoimmun; 2006 Dec; 27(4):242-50. PubMed ID: 17257812
[TBL] [Abstract][Full Text] [Related]
37. Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus.
Ju S; Zhang D; Wang Y; Ni H; Kong X; Zhong R
Clin Biochem; 2006 Dec; 39(12):1131-7. PubMed ID: 17069785
[TBL] [Abstract][Full Text] [Related]
38. B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.
Hong SD; Reiff A; Yang HT; Migone TS; Ward CD; Marzan K; Shaham B; Phei WC; Garza J; Bernstein B; Stohl W
Arthritis Rheum; 2009 Nov; 60(11):3400-9. PubMed ID: 19877053
[TBL] [Abstract][Full Text] [Related]
39. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
Brugos B; Kiss E; Dul C; Gubisch W; Szegedi G; Sipka S; Zeher M
Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031
[TBL] [Abstract][Full Text] [Related]
40. Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis.
Kang EH; Moon KC; Lee EY; Lee YJ; Lee EB; Ahn C; Song YW
Lupus; 2009 Jan; 18(1):22-8. PubMed ID: 19074165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
